Effect of Vetiveria zizanioides essential oil on melanogenesis in melanoma cells: downregulation of tyrosinase expression and suppression of oxidative stress.
Melanin is a pigment that is widely distributed in the skin surface, hair, retina, and adrenal medullae and is biosynthesized from tyrosine through the enzymatic oxidation of tyrosinase . Melanogenesis is primarily stimulated by the ultraviolet- (UV-) induced a-melanin-stimulating hormone ([alpha]-MSH) in melanocytes . Moreover, melanin is thought to play an important role in skin cancer prevention through the protection of cells from UV radiation. However, increased amounts of melanin are observed in a large number of skin diseases and affect skin esthetics . Accordingly, skin whitening agents from synthetic or natural resources are under development for both beauty and therapeutic purposes.
Tyrosinase (EC 220.127.116.11) is the key enzyme that acts in the initial step of melanin biosynthesis. This enzyme catalyzes the oxidation of L-tyrosine to 3,4-dihydroxyphenylalanine (DOPA) and of DOPA to dopaquinone, which is then processed to dopachrome and eumelanin in the absence of cysteine (Cys) . In contrast, in the presence of cysteine, dopaquinone rapidly reacts with cysteine to yield cysteinyldopas, which are then oxidized to produced benzothiazine intermediates and ultimately pheomelanin . Glutathione (GSH) and its precursor, cysteine, are well known to react with oxidative species in cells and play an important role in the cellular protection system against reactive oxidative species (ROS) [5, 6]. Therefore, the melanogenesis-mediated decrease of glutathione and cysteine is recognized as an oxidative stress for melanocytes .
Vetiveria zizanioides (vetiver grass), which is a perennial tussock grass of the Gramineae family, is famous as an eco friendly plant. This grass can prevent soil erosion and is used in the treatment of metalliferous-polluted ground due to its tolerance to heavy metals . V zizanioides has also been cultivated for many industrial applications, including the production of the commercially and medicinally valued volatile oil that can be distilled from its root [7, 8]. V. zizanioides essential oil (VZ-EO) has been frequently used as a functional ingredient and fragrance in foods, aromatic products, and cosmetics. The vetiver oil is an expensive edible oil in the Chinese market and which has also been used in India in many ways as a food additive, such as flavoring syrups, ice cream, and beverages and for food preservation. Moreover, VZ-EO is commonly used as traditional medicine in Thailand and India for the treatment of numerous syndromes, such as gastritis, fever, headache, mouth ulcers, toothache, and chronic inflammation [9,10].
In a previous study, we demonstrated that the anti-inflammatory activity of VZ-EO correlates with its antioxidant activity, which decreases the lipopolysaccharide-(LPS-) stimulated superoxide anion production and the malondialdehyde (MDA) levels in macrophages . However, the antimelanogenic activity of VZ-EO has not been studied to date. Therefore, the major objective of this study was to estimate the hypopigmentation function of VZ-EO. The relationship between the antioxidant function and the antimelanogenic activity of VZ-EO in [alpha]-MSH-treated melanocytes was also investigated in this study.
2.1. Chemical and Reagents. The steam distilled essential oil of Vetiveria zizanioides (VZ-EO) was purchased from Lorien Vana Biotech, Inc., Taiwan. The [alpha]-melanocyte stimulating hormone ([alpha]-MSH), dimethyl sulfoxide (DMSO), monobromobimane (MbBr), and phenylmethylsulfonyl fluoride (PMSF) were purchased from Sigma-Aldrich Chemicals Co. (St. Louis, MO, USA). The L-3,4-dihydroxyphenylalanine (LDOPA) that was used in this study was purchased from Merck (Darmstadt, Germany). Dulbecco's modified eagle medium (DMEM), fetal bovine serum (FBS), L-glutamine, and penicillin-streptomycin were purchased from Invitrogen Life Technologies (Carlsbad, CA, USA). The goat antityrosinase antibody and rabbit anti-[beta]-actin antibody were purchased from Santa Cruz Biotechnology (CA, USA). The enhanced chemiluminescence (ECL) kit was purchased from Amersham Biosciences (NJ, USA). All of the other chemicals that were used were at least of reagent grade. The deionized distilled water (dd[H.sub.2]O) used for the preparation of solutions and buffers was purified using a Milli-Q system (Millipore, Bedford, MA, USA).
2.2. Determination of Antioxidant Activity through the [beta]-Carotene Bleaching Assay. The antioxidant activity was evaluated according to the [beta]-carotene bleaching method . First, 0.1 mg of [beta]-carotene was dissolved in 5mL of chloroform. One milliliter of the chloroform solution was mixed with 20 [micro]L of linoleic acid and 200 mg of Tween-80 and concentrated using [N.sub.2]. Then, 50 mL of oxygenated water was added and mixed. The emulsion obtained was freshly prepared before each experiment. A volume of 40 mL of VZ-EO (10 [micro]g/mL) or positive control (10 [micro]g/mL BHA) was added to 960 mL of the [beta]-carotene/linoleic acid emulsion. An equal amount of methanol was used for the control. The reaction mixture was maintained at 50[degrees]C, and the absorbance was measured at 470 nm. The absorbances of all of the samples were read immediately (at the zero time point) and every 30 min up to 180 min.
2.3. Gas Chromatography and Mass Spectrometry Analysis. The essential oil was analyzed through gas chromatographymass spectrometry (GC-MS) to identify its constituents. The GC-MS (GCMS-QP2010 Plus, Shimadzu, Japan) was equipped with a Forte ID-BPX5 column (30.0 m x 0.25 mm i.d., 0.25 [micro]m film thickness, SGE, AU), and the injector temperature was maintained at 250[degrees]C. Helium (He) was used as the carrier gas at a flow rate of 1mL/min, and the split ratio was set to 1: 100. The initial oven temperature was maintained at 50[degrees]C for 5 min and then programmed to increase at a rate of 5[degrees]C/min to 150[degrees] C and then at a rate of 10[degrees]C/min to 300[degrees]C. The mass spectrometry conditions were as follows: scan range, 40-350 amu; ion source temperature, 230[degrees]C; and interface temperature, 250[degrees]C. The essential oil constituents were identified by comparing the retention times and retention indices of the chromatographic peaks with a standard library from the National Institute of Standards and Technology (NIST) MS spectral database (version, 2005) and by comparing the measured Kovats index (KI) to a homologous series of n-alkanes ([C.sub.5]-[C.sub.26]).
2.4. Cell Cultures. The B16 murine melanoma cell line was purchased from the Bioresource Collection and Research Center (BCRC; Hsinchu, Taiwan). The B16 cells were cultured in DMEM supplemented with 10% FBS, 2mM glutamine, 100 mg/mL streptomycin, and 100 U/mL penicillin. The cells were maintained in a humidified 5% C[O.sub.2] incubator at 37[degrees]C and were subcultured every 3 to 4 days to maintain logarithmic growth.
2.5. Cell Viability. The B16 cells were seeded in a 96-well plate at a density of 5 x 103 cells/well. After the plate was incubated for 24 h, different concentrations of the samples and 10 nM [alpha]-MSH were added to each well; the plate was then incubated for an additional 72 h. The cell viability was then determined using the improved MTT assay .
2.6. Melanin Content Assay. The method described by Thanigaimalai et al.  was used to determine the melanin content of the B16 cells. These cells were incubated with various concentrations of VZ-EO (2.5, 5.0,10, or 20 [micro]g/mL) and were subsequently cotreated with 10 nM [alpha]-MSH for 72 h. After this treatment, the cells were dissolved in a 1 M NaOH 10% DMSO solution and incubated at 90[degrees]C to solubilize the melanin. The total melanin in each cell suspension was determined by the absorbance of each suspension at 405 nm. The melanin content was calculated by interpolating the results onto a standard curve that was generated by the absorbance of known concentrations of synthetic melanin and correcting the total amounts of protein that are present in the cell lysate supernatants.
2.7. Cellular Tyrosinase Activity Assay. The cellular tyrosinase activity was assayed based on the DOPA oxidase activity using the method described by Seo et al. . The B16 cells were incubated with various concentrations of VZ-EO (2.5, 5.0, 10, or 20 [micro]g/mL) and were subsequently cotreated with 10 nM [alpha]-MSH for 72 h. At the end of this treatment, the cells were sonicated with phosphate buffer (pH 6.8) containing 1 mM PMSF. The lysates were clarified through centrifugation at 10,000 xg for 10 min. After the protein in each lysate was quantified and protein concentration was adjusted with lysis buffer, 300 [micro]L of each lysate was mixed with 700 [micro]L of 5 mM L-DOPA. This mixture was incubated for 1h at 37[degrees]C, and the absorbance was then measured spectrophotometrically at 475 nm.
2.8. Western Blot Assay. The B16 cells were incubated with various concentrations of VZ-EO (2.5, 5.0,10, or 20 [micro]g/mL) and were subsequently cotreated with 10 nM [alpha]-MSH for 72 h. After this treatment, the cells were sonicated with phosphate buffer (pH 6.8) containing 1 mM PMSF, and the lysates were collected and then quantified. For western blotting, each well was loaded with 20 ng of protein, resolved by 12% SDS PAGE, and then electrotransferred onto a polyvinylidene difluoride (PVDF) membrane using a Bio-Rad Mini-Protean II apparatus (Bio-Rad Laboratories, Carlsbad, CA, USA). The blots were subsequently incubated with goat antityrosinase antibody or rabbit anti-[beta]-actin antibody as primary antibodies, and the immune complexes were visualized using the ECL reagent. The bands were scanned and then quantified by measuring the optical densities using the VIpro Platinum 1.1 software (Version 12.9; UVItec, UK).
2.9. Measurement of Lipid Peroxide and Glutathione (GSH) Levels and Glutathione Peroxidase (GPX), Superoxide Dismutase (SOD), and Catalase (CAT) Activities. B16 cells were incubated with various concentrations of VZ-EO (2.5, 5.0, 10, or 20 [micro]g/mL) and subsequently cotreated with 10 nM [alpha]-MSH for 72 h. At the end of the treatment, the cells were harvested and sonicated with phosphate buffer (pH 6.8) containing 1mM PMSF to obtain cell homogenates. The thiobarbituric acid-reactive substances (TBARS) method was used to estimate the cellular malondialdehyde (MDA) levels by measuring the absorbance at 535 nm with a spectrophotometer . The cellular GSH was reduced with a dithiothreitol/phosphate solution and derivatized with MbBr prior to HPLC analysis .
With respect to the GPX activity, one unit of GPX activity was defined as the amount of enzyme that oxidized 1 nM NADPH per minute, as measured by the absorbance at 340 nm . The superoxide dismutase (SOD) activity was determined spectrophotometrically at 325 nm by determining the SOD-mediated decrease in the rate of pyrogallol autoxidation under alkaline conditions . One unit of SOD activity was defined as the amount of enzyme that inhibited the rate of pyrogallol oxidation. The catalase (CAT) activity was analyzed by measuring the decrease in the absorbance of [H.sub.2][O.sub.2] at 240 nm. One unit of CAT activity was defined as the amount of enzyme that decomposed 1.0 [micro]M [H.sub.2][O.sub.2] per minute . The specific activities of SOD, CAT, and GPX are expressed in terms of units/mg protein.
2.10. Statistical Analysis. All of the measurements were conducted at least three times with three different sample preparations. All the data were expressed as the means [+ or -] standard deviation (SD). The analysis of variance was performed using the SPSS software (version 16.0; SPSS Inc., USA). One-way ANOVA and Scheffe's method were used to determine the differences between the means, and differences with P < 0.05 were considered to be statistically significant.
3. Results and Discussion
3.1. Antioxidant Activity of VZ-EO. The in vitro inhibitory activity of VZ-EO on lipid peroxidation was first established in this study through the [beta]-carotene bleaching method. In the absence of an antioxidant, [beta]-carotene undergoes rapid decolorization because it is attacked by free linoleic acid radicals. The results are shown in Figure 1. Compared with the control group, 10 [member of]g/mL VZ-EO can markedly slow down the decrease in the absorbance at 470 nm from 0 to 180 min. Moreover, its antioxidative performance on lipid peroxidation is comparable to that of the potent antioxidant BHA (Figure 1). Therefore, we confirmed that VZ-EO exhibits significant antioxidant activity on lipid peroxidation, and this result is similar to the findings reported by several earlier studies [10, 11].
3.2. Effect of VZ-EO on Cell Viability and Melanin Content in [alpha]-MSH-Stimulated B16 Cells. To evaluate the effect of VZ-EO on [alpha]-MSH-stimulated B16 cells and to determine appropriate concentrations of VZ-EO for the subsequent analyses, the standard MTT assay was used to test the effect of VZ-EO on the B16 cell viability, and the results are shown in Figure 2(a). All of the tested concentrations (from 2.5 to 20 [micro]g/mL) of VZEO did not alter the proliferation of the [alpha]-MSH-stimulated B16 cells. Thus, all of the tested concentrations of VZ-EO were then used for the following experiments.
The effect of VZ-EO on the melanin content in [alpha]-MSH-stimulated B16 cells was tested and is shown in Figure 2(b). The results demonstrated that VZ-EO can suppress melanin production in [alpha]-MSH-stimulated B16 cells. The melanin content in the [alpha]-MSH-stimulated group increased to approximately 62 [micro]g/mg protein. As the concentration of VZ-EO increased from 2.5 to 20 [micro]g/mL, the melanin contents of the [alpha]-MSH-stimulated B16 cells treated with VZ-EO were reduced to only 38 to 24 [micro]g/mg protein (Figure 2(b)). Therefore, this is the first demonstration that VZ-EO can markedly decrease the [alpha]-MSH-induced melanin production in B16 cells.
3.3. Effect of VZ-EO on Cellular Tyrosinase Activity and Tyrosinase Protein Expression in [alpha]-MSH-Stimulated B16 Cells. Both eumelanin and pheomelanin are derived from the same precursor amino acid, namely, L-tyrosine, through tyrosinase. Thus, tyrosinase is recognized as the rate-limiting enzyme in melanin biosynthesis in melanocytes . To verify the effect of VZ-EO on melanin production, we tested the cellular tyrosinase activity in [alpha]-MSH-stimulated B16 cells, and the results are shown in Figure 3(a). Similar to the results obtained from the melanin content assay that are shown in Figure 2(b), the activity of tyrosinase in B16 cells was induced by [alpha]-MSH and reduced by treatment with VZ-EO. VZ-EO concentrations of 10 to 20 [micro]g/mL can strongly decrease the tyrosinase activities to approximately half of that obtained in the [alpha]-MSH-stimulated cells (Figure 3(a)).
To further verify the control point of VZ-EO on B16 melanin production, we analyzed the protein expression of tyrosinase by western blot analysis, and the results are displayed in Figure 3(b). The results clearly demonstrate that VZ-EO can decrease the [alpha]-MSH-induced increase in tyrosinase expression in B16 cells in a dose-dependent manner. In fact, treatment with 10 and 20 [micro]g/mL VZ-EO can decrease the expression of tyrosinase to 81 and 52% compared with the unstimulated control cells (Figure 3(b)). Therefore, we can hypothesize that the antimelanogenic activity of VZEO is implemented through the downregulation of both the activity and the protein level of tyrosinase and that this downregulation results in dose-dependent decreases in the melanin content of cells. Based on the aforementioned results, VZ-EO suppresses the [alpha]-MSH-stimulated melanogenesis in murine B16 melanoma cells through noncytotoxic mechanisms that involve the inhibition of tyrosinase activity and the downregulation of tyrosinase expression.
3.4. Effect of VZ-EO on MDA Production, GSH Levels, and Antioxidant Enzyme Activities in [alpha]-MSH-Stimulated B16 Cells. The oxidation of L-DOPA generates a highly reactive intermediate that is further oxidized to form melanin through a radical-coupling pathway. In fact, melanogenesis has been reported to involve not only the production of hydrogen peroxide ([H.sub.2][O.sub.2]) by means of enzymatic and nonenzymatic reactions but also the subsequent generation of other reactive oxygen species (ROS), which cause oxidative stress for melanocytes . Oxidative stress is considered the result of an imbalance between oxidants and antioxidants within the cell. Additionally, [alpha]-MSH-induced melanogenesis is associated with ROS generation . Therefore, antioxidants, tyrosinase inhibitors, and ROS scavengers may downregulate melanogenesis. Many previous studies have reported that various antioxidants, including gallic acid , curcumin , and ascorbic acid , may exhibit antimelanogenic effects. Therefore, we investigated whether exposure to VZ-EO would reduce the oxidative stress in [alpha]-MSH-stimulated cells.
First, the level of lipid peroxidation was measured based on the production of MDA to determine the cellular oxidative stress induced by [alpha]-MSH. As shown in Figure 4(a), the MDA level in [alpha]-MSH-stimulated B16 cells was increased to 3.4 nmol/mg protein. However, VZ-EO (at concentrations from 2.5 to 20 [micro]g/mL) reduces the cellular MDA levels in a dose-dependent manner. Treatment with 20 [micro]g/mL VZEO decreased the [alpha]-MSH-stimulated MDA levels to a level that was almost the same as that observed in unstimulated cells. The level of GSH is important for maintaining the cellular redox status and plays an important role in the inhibition of melanogenesis . Our data indicated that the GSH level in B16 cells was reduced by [alpha]-MSH treatment to only 43.7 nmol/mg protein. However, increasing concentrations of VZ-EO noticeably improved the cellular GSH levels (Figure 4(b)). Although the GSH levels in the VZ-EO-treated B16 cells did not return to the basal level, our results demonstrate that VZ-EO has the ability to decrease the [alpha]-MSH-activated oxidative stress in B16 cells.
Various antioxidant enzymes, such as GPX, SOD, and CAT, play important roles in maintaining the redox homeostasis within cells. A previous study revealed that gallic acid exhibits a protective effect on UV-mediated melanogenesis through improvement of the GSH-related antioxidant defenses . Amikacin, which is an antibiotic derived from kanamycin, can modulate melanogenesis in melanocytes by the regulation of the antioxidant defense system, including the activities of SOD, GPX, and CAT . To further evaluate the antioxidant activity of VZ-EO, we analyzed the activities of these important cellular antioxidative enzymes in [alpha]-MSH-stimulated B16 cells. The results are shown in Figure 5. The activities of all of the tested antioxidative enzymes in the [alpha]-MSH-treated cells were reduced. In addition, all of the tested antioxidative enzyme activities returned to their normal levels in [alpha]-MSH-stimulated B16 cells treated with 20 [micro]g/mL VZ-EO (Figure 5). Although the effects of both [alpha]-MSH and VZ-EO on the CAT activity in B16 cells were not obvious (Figure 5(c)), the results confirmed that the effect of VZ-EO on the activity of CAT was similar to the effect observed in the activities of SOD (Figure 5(a)) and GPX (Figure 5(b)). Therefore, we hypothesized that VZ-EO can increase the activities of cellular SOD, GPX, and CAT to suppress the oxidative stress induced by [alpha]-MSH in B16 cells.
Therefore, our data demonstrate that depletion of the GSH content and aggravation of oxidative stress could be involved in the melanogenesis response induced by [alpha]-MSH in B16 melanoma cells. VZ-EO can repress the oxidative stress and lipid peroxidation in [alpha]-MSH-stimulated cells because this treatment increases both the levels of GSH and the activities of SOD and GPX within these cells and thereby reduces oxidant formation. Based on our results, we conclude that VZ-EO is able to suppress the [alpha]-MSH-induced melanogenesis through tyrosinase inactivation and the simultaneous suppression of oxidative stress in B16 melanoma cells. The proposed mechanism is shown in Figure 6.
3.5. Analysis of the Components of VZ-EO. The functions of an essential oil are often provided by its complex composition. Therefore, the activity of such functional ingredients cannot be easily explained by a few major compounds. However, to further clarify the effects of VZ-EO, the chemical composition of VZ-EO was also determined and is shown in Table 1. As shown in Table 1, the most abundant component of VZ-EO is cedr-8-en-13-ol (12.4%). Other major compounds of VZ-EO are [alpha]-amorphene (7.80%), [beta]-vatirenene (5.94%), [alpha]-gurjunene (5.91%), and dehydroaromadendrene (5.45%). A previous study conducted by Tepe et al.  reported that the essential oil of Peucedanum longifolium contains 33.74% cedr-8-en-13-ol and exhibited a strong ability to inhibit lipid peroxidation. Moreover, the antioxidant and biological functions of V. zizanioides have been described by some previous studies [10,11]. Therefore, the results obtained in this study might explain insight into the antioxidant function and antimelanogenic activity of VZ-EO.
In summary, VZ-EO exhibits powerful antioxidative activity on lipid peroxidation to moderate the bleaching of [beta]-carotene and to maintain the cellular GSH level. VZ-EO can markedly decrease melanin production in [alpha]-MSH-stimulated B16 cells. The effect of VZ-EO on the melanogenesis induced by [alpha]-MSH in B16 cells is achieved through the suppression of cellular tyrosinase expression. The function of VZ-EO on melanogenesis might result from its potent antioxidative ability, which is reflected by the restoration of the cellular SOD, GPX, and CAT activities in [alpha]-MSH-stimulated B16 cells. The most abundant component of VZ-EO is cedr8-en-13-ol (12.4%), which has the ability to inhibit lipid peroxidation strongly. Therefore, VZ-EO has the potential to become an ingredient in future hypopigmentation drugs, foods, and cosmetics.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
The authors are grateful for the financial support provided by the National Science Council of Taiwan to Dr. Su-Tze Chou (NSC102-2313-B-126-004-MY3) and Dr. Chih-Chien Lin (NSC102-2313-B-126-001-MY3).
 J. M. Gillbro and M. J. Olsson, "The melanogenesis and mechanisms of skin-lightening agents--existing and new approaches," International Journal of Cosmetic Science, vol. 33, no. 3, pp. 210221, 2011.
 A. Roulin, B. Almasi, K. S. Meichtry-Stier, and L. Jenni, "Eumelanin- and pheomelanin-based colour advertise resistance to oxidative stress in opposite ways," Journal of Evolutionary Biology, vol. 24, no. 10, pp. 2241-2247, 2011.
 C.-X. Tu, M. Lin, S.-S. Lu, X.-Y. Qi, R.-X. Zhang, and Y.-Y. Zhang, "Curcumin inhibits melanogenesis in human melanocytes," Phytotherapy Research, vol. 26, no. 2, pp. 174-179, 2012.
 Y.-S. Chen, S.-M. Lee, C.-C. Lin, C.-Y. Liu, M.-C. Wu, and W.-L. Shi, "Kinetic study on the tyrosinase and melanin formation inhibitory activities of carthamus yellow isolated from Carthamus tinctorius L," Journal of Bioscience and Bioengineering, vol. 115, no. 3, pp. 242-245, 2013.
 E. Kinnaert, P. Duez, R. Morandini, J. Dubois, P. van Houtte, and G. Ghanem, "Cysteine but not glutathione modulates the radiosensitivity of human melanoma cells by affecting both survival and DNA damage," Pigment Cell Research, vol. 17, no. 3, pp. 275-280, 2004.
 S. E. Tobi, N. Paul, and T. J. McMillan, "Glutathione modulates the level of free radicals produced in UVA-irradiated cells," Journal of Photochemistry and Photobiology B: Biology, vol. 57, no. 2-3, pp. 102-112, 2000.
 K. K. Chiu, Z. H. Ye, and M. H. Wong, "Growth of Vetiveria zizanioides and Phragmities australis on Pb/Zn and Cu mine tailings amended with manure compost and sewage sludge: a greenhouse study," Bioresource Technology, vol. 97, no. 1, pp. 158-170, 2006.
 L. del Giudice, D. R. Massardo, P Pontieri et al., "The microbial community of Vetiver root and its involvement into essential oil biogenesis," Environmental Microbiology, vol. 10, no. 10, pp. 2824-2841, 2008.
 N. Aibibu, Y. Liu, G. Zeng et al., "Cadmium accumulation in Vetiveria zizanioides and its effects on growth, physiological and biochemical characters," Bioresource Technology, vol. 101, no. 16, pp. 6297-6303, 2010.
 S. Luqman, R. Kumar, S. Kaushik, S. Srivastava, M. P Darokar, and S. P S. Khanuja, "Antioxidant potential of the root of Vetiveria zizanioides (L.) Nash," Indian Journal of Biochemistry and Biophysics, vol. 46, no. 1, pp. 122-125, 2009.
 S.-T. Chou, C.-P Lai, C.-C. Lin, and Y. Shih, "Study of the chemical composition, antioxidant activity and anti-inflammatory activity of essential oil from Vetiveria zizanioides," Food Chemistry, vol. 134, no. 1, pp. 262-268, 2012.
 A. A. Elzaawely, T. D. Xuan, and S. Tawata, "Antioxidant and antibacterial activities of Rumex japonicus HOUTT. Aerial parts," Biological and Pharmaceutical Bulletin, vol. 28, no. 12, pp. 2225-2230, 2005.
 D. Sladowski, S. J. Steer, R. H. Clothier, and M. Balls, "An improved MTT assay," Journal of Immunological Methods, vol. 157, no. 1-2, pp. 203-207, 1993.
 P Thanigaimalai, K.-C. Lee, S.-C. Bang et al., "Evaluation of 3,4-dihydroquinazoline-2(1H)-thiones as inhibitors of [alpha]-MSH-induced melanin production in melanoma B16 cells," Bioorganic & Medicinal Chemistry, vol. 18, no. 4, pp. 1555-1562, 2010.
 W. D. Seo, Y. B. Ryu, M. J. Curtis-Long et al., "Evaluation of anti-pigmentary effect of synthetic sulfonylamino chalcone," European Journal of Medicinal Chemistry, vol. 45, no. 5, pp. 2010-2017, 2010.
 N. A. Botsoglou, D. J. Fletouris, G. E. Papageorgiou, V. N. Vassilopoulos, A. J. Mantis, and A. G. Trakatellis, "Rapid, sensitive, and specific thiobarbituric acid method for measuring lipid peroxidation in animal tissue, food, and feedstuff samples," Journal of Agricultural and Food Chemistry, vol. 42, no. 9, pp. 1931-1937, 1994.
 C.-S. Yang, S.-T. Chou, L. Liu, P-J. Tsai, and J.-S. Kuo, "Effect of ageing on human plasma glutathione concentrations as determined by high-performance liquid chromatography with fluorimetric detection," Journal of Chromatography B: Biomedical Applications, vol. 674, no. 1, pp. 23-30, 1995.
 D. E. Paglia and W. N. Valentine, "Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase," The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158-169, 1967
 S. Marklund and G. Marklund, "Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase," European Journal of Biochemistry, vol. 47, no. 3, pp. 469-474, 1974.
 H. Aebi, "Catalase in vitro" Methods in Enzymology, vol. 105, pp. 121-126, 1984.
 J. L. Munoz-Munoz, F. Garcia-Molina, R. Varon, J. Tudela, F. Garcia-Canovas, and J. N. Rodriguez-Lopez, "Generation of hydrogen peroxide in the melanin biosynthesis pathway," Biochimica et Biophysica Acta, vol. 1794, no. 7, pp. 1017-1029, 2009.
 G.-S. Liu, H. Peshavariya, M. Higuchi et al., "Microphthalmia associated transcription factor modulates expression of NADPH oxidase type 4: a negative regulator of melanogenesis," Free Radical Biology and Medicine, vol. 52, no. 9, pp. 1835-1843, 2012.
 Y.-J. Kim, "Antimelanogenic and antioxidant properties of gallic acid," Biological and Pharmaceutical Bulletin, vol. 30, no. 6, pp. 1052-1055, 2007.
 U. Panich, V. Tangsupa-A-Nan, T. Onkoksoong et al., "Inhibition of UVA-mediated melanogenesis by ascorbic acid through modulation of antioxidant defense and nitric oxide system," Archives of Pharmacal Research, vol. 34, no. 5, pp. 811-820, 2011.
 C. D. Villarama and H. I. Maibach, "Glutathione as a depigmenting agent: an overview," International Journal of Cosmetic Science, vol. 27, no. 3, pp. 147-153, 2005.
 U. Panich, T. Onkoksoong, S. Limsaengurai, P. Akarasereenont, and A. Wongkajornsilp, "UVA-induced melanogenesis and modulation of glutathione redox system in different melanoma cell lines: the protective effect of gallic acid," Journal of Photochemistry and Photobiology B: Biology, vol. 108, pp. 16-22, 2012.
 D. Wrzesniok, A. Beberok, M. Otreba, and E. Buszman, "Modulation of melanogenesis and antioxidant defense system in melanocytes by amikacin," Toxicology in Vitro, vol. 27, no. 3, pp. 1102-1108, 2013.
 B. Tepe, H. A. Akpulat, and M. Sokmen, "Evaluation of the chemical composition and antioxidant activity of the essential oils of Peucedanum longifolium (Waldst. & Kit.) and P. palimbioides (Boiss.)," Records of Natural Products, vol. 5, no. 2, pp. 108-116, 2011.
Hsin-Yi Peng, (1) Chin-Chun Lai, (1) Chih-Chien Lin, (2) and Su-Tze Chou (1)
(1) Department of Food and Nutrition, Providence University, No. 200, Section 7, Taiwan Boulevard, Shalu, Taichung 43301, Taiwan
(2) Department of Cosmetic Science, Providence University, No. 200, Section 7, Taiwan Boulevard, Shalu, Taichung 43301, Taiwan
Correspondence should be addressed to Chih-Chien Lin; email@example.com and Su-Tze Chou; firstname.lastname@example.org
Received 18 December 2013; Accepted 23 February 2014; Published 19 March 2014
Academic Editors: M. Bouchenak and B. Sharma
TABLE 1: GC-MS analysis of the essential oil from Vetiveria zizanioides (VZ-EO). Compound Rt KI Area (%) 2,3,5,5,8,8-Hexamethyl-cycloocta- 23.19 1314 2.28 1,3,6-triene 1,5,9,9-Tetramethyl-2-methylene- 24.08 1328 3.96 spiro[3.5]non-5-ene (+)-Sativen 25.51 1339 2.83 4,8,8-Trimethyl-2-methylene-4- 25.62 1407 4.53 vinylbicyclo[5.2.0]nonane [alpha]-Amorphene 26.05 1440 7.80 2-Isopropenyl-1,3,5-trimethylbenzene 26.14 1465 2.43 [alpha]-Gurjunene 26.22 1479 5.91 [beta]-Vatirenene 26.30 1489 5.94 [delta]-Cadinene 26.55 1499 2.57 [beta]-Guaiene 26.93 1523 4.28 Dehydroaromadendrene 27.05 1545 5.45 Cubenol 28.82 1580 2.09 (+)-Ledene 29.28 1605 4.77 Epiglobulol 29.42 1632 2.21 Widdrol 29.90 1651 2.13 6-Isopropenyl-4,8a-dimethyl- 30.04 1690 1.97 1,2,3,5,6,7,8,8a-octahydro- naphthalen-2-ol 3-(2-Isopropyl-5-methylphenyl)-2- 30.17 1745 3.17 methylpropionic acid Cedr-8-en-13-ol 30.67 1769 12.36 Ethyl 4-(4-methylphenyl)-4- 31.06 1804 2.12 pentenoate Isovellerdiol 31.11 1842 2.38 [alpha]-Curcumene 31.16 1867 2.44 3,3,8,8-Tetramethyl- 31.38 1890 4.82 tricyclo[18.104.22.168(2,4)]oct-5-ene-5- propanoic acid Solavetivone 31.46 1906 4.20 3,8-Dimethyl-4-(1-methylethylidene)- 31.82 1925 4.89 2,4,6,7,8,8a-hexahydro-5(1H)- azulenone (-)-Spathulenol 31.88 1938 2.47 Compound M.f. 2,3,5,5,8,8-Hexamethyl-cycloocta- [C.sub.14][H.sub.22] 1,3,6-triene 1,5,9,9-Tetramethyl-2-methylene- [C.sub.14][H.sub.22] spiro[3.5]non-5-ene (+)-Sativen [C.sub.15][H.sub.24] 4,8,8-Trimethyl-2-methylene-4- [C.sub.15][H.sub.24] vinylbicyclo[5.2.0]nonane [alpha]-Amorphene [C.sub.15][H.sub.24] 2-Isopropenyl-1,3,5-trimethylbenzene [C.sub.12][H.sub.16] [alpha]-Gurjunene [C.sub.15][H.sub.24] [beta]-Vatirenene [C.sub.15][H.sub.22] [delta]-Cadinene [C.sub.15][H.sub.24] [beta]-Guaiene [C.sub.15][H.sub.24] Dehydroaromadendrene [C.sub.15][H.sub.22] Cubenol [C.sub.15][H.sub.26]O (+)-Ledene [C.sub.15][H.sub.24] Epiglobulol [C.sub.15][H.sub.26]O Widdrol [C.sub.15][H.sub.26]O 6-Isopropenyl-4,8a-dimethyl- [C.sub.15][H.sub.24]O 1,2,3,5,6,7,8,8a-octahydro- naphthalen-2-ol 3-(2-Isopropyl-5-methylphenyl)-2- [C.sub.14][H.sub.26][O.sub.2] methylpropionic acid Cedr-8-en-13-ol [C.sub.15][H.sub.24]O Ethyl 4-(4-methylphenyl)-4- [C.sub.16][H.sub.26][O.sub.3] pentenoate Isovellerdiol [C.sub.15][H.sub.24][O.sub.2] [alpha]-Curcumene [C.sub.15][H.sub.22] 3,3,8,8-Tetramethyl- [C.sub.15][H.sub.22][O.sub.2] tricyclo[22.214.171.124(2,4)]oct-5-ene-5- propanoic acid Solavetivone [C.sub.15][H.sub.22]O 3,8-Dimethyl-4-(1-methylethylidene)- [C.sub.15][H.sub.22]O 2,4,6,7,8,8a-hexahydro-5(1H)- azulenone (-)-Spathulenol [C.sub.15][H.sub.24]O Rt: retention time (min); KI: Kovats index; M.f.: molecular formula.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Research Article|
|Author:||Peng, Hsin-Yi; Lai, Chin-Chun; Lin, Chih-Chien; Chou, Su-Tze|
|Publication:||The Scientific World Journal|
|Date:||Jan 1, 2014|
|Previous Article:||Fractal analysis of Laplacian pyramidal filters applied to segmentation of soil images.|
|Next Article:||Impact strength and flexural properties enhancement of methacrylate silane treated oil palm mesocarp fiber reinforced biodegradable hybrid composites.|